HU201681B - Process for producing retarde parenteral pharmaceutical composition containing growth hormone - Google Patents

Process for producing retarde parenteral pharmaceutical composition containing growth hormone Download PDF

Info

Publication number
HU201681B
HU201681B HU881137A HU113788A HU201681B HU 201681 B HU201681 B HU 201681B HU 881137 A HU881137 A HU 881137A HU 113788 A HU113788 A HU 113788A HU 201681 B HU201681 B HU 201681B
Authority
HU
Hungary
Prior art keywords
growth hormone
polysaccharide
pharmaceutical composition
animals
retarde
Prior art date
Application number
HU881137A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT47220A (en
Inventor
Volker Dietrich Arendt
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of HUT47220A publication Critical patent/HUT47220A/hu
Publication of HU201681B publication Critical patent/HU201681B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y10S530/814—Cellulose or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU881137A 1987-03-09 1988-03-09 Process for producing retarde parenteral pharmaceutical composition containing growth hormone HU201681B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/023,427 US4857505A (en) 1987-03-09 1987-03-09 Sustained release compositions for parenteral administration and their use

Publications (2)

Publication Number Publication Date
HUT47220A HUT47220A (en) 1989-02-28
HU201681B true HU201681B (en) 1990-12-28

Family

ID=21815030

Family Applications (1)

Application Number Title Priority Date Filing Date
HU881137A HU201681B (en) 1987-03-09 1988-03-09 Process for producing retarde parenteral pharmaceutical composition containing growth hormone

Country Status (14)

Country Link
US (1) US4857505A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0281809B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS63253030A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE92329T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU603189B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1318249C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3882748D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK124288A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI881061L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3009565T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU201681B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL85476A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ223715A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA881657B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336506A (en) * 1986-07-03 1994-08-09 Advanced Magnetics Inc. Targeting of therapeutic agents using polysaccharides
US5011918A (en) * 1987-10-26 1991-04-30 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US4929670A (en) * 1987-10-26 1990-05-29 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
DE69125595T2 (de) * 1990-10-18 1997-11-13 Shiseido Co. Ltd., Tokio/Tokyo Kombination von hyaluronsäure mit einem medizinischen bestandteil, und seine herstellung
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
ATE151991T1 (de) * 1990-12-19 1997-05-15 Advanced Magnetics Inc Targeting von therapeutischen mitteln durch verwendung von polysacchariden
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6284727B1 (en) * 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
WO2001003741A1 (en) * 1999-07-12 2001-01-18 Grandis Biotech Gmbh Growth hormone formulations
CN1095472C (zh) * 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
CN1635901B (zh) * 2001-10-10 2012-03-28 诺和诺德公司 肽的重构和糖缀合的方法
RU2200216C1 (ru) * 2002-05-08 2003-03-10 Санкт-Петербургский государственный технологический университет растительных полимеров Волокнистый материал для защиты от бытовых насекомых
AU2003250915A1 (en) * 2002-07-09 2004-01-23 Sandoz Ag LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL
CN113398273B (zh) * 2021-05-14 2022-07-19 广西壮族自治区中国科学院广西植物研究所 木聚糖衍生物作为亲水性缓释材料在制备药物缓释片中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514650A (fr) * 1967-05-23 1971-10-31 Pharmacia Ab Procédé de préparation de dérivés de peptides insolubles dans l'eau
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US3947352A (en) * 1974-05-31 1976-03-30 Pedro Cuatrecasas Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
CA1167403A (en) * 1979-07-10 1984-05-15 Unilever Limited Microbial heteropolysaccharide
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
EP0211601A3 (en) * 1985-07-30 1988-01-13 International Minerals And Chemical Corporation Stabilization of growth promoting hormones
ZA866218B (en) * 1985-08-23 1988-03-30 Lilly Co Eli Injectable sustained release formulation
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.

Also Published As

Publication number Publication date
EP0281809B1 (en) 1993-08-04
FI881061A7 (fi) 1988-09-10
AU603189B2 (en) 1990-11-08
US4857505A (en) 1989-08-15
HUT47220A (en) 1989-02-28
FI881061L (fi) 1988-09-10
DK124288A (da) 1988-09-10
IL85476A (en) 1991-08-16
JPS63253030A (ja) 1988-10-20
DE3882748D1 (de) 1993-09-09
EP0281809A2 (en) 1988-09-14
ATE92329T1 (de) 1993-08-15
NZ223715A (en) 1990-11-27
DK124288D0 (da) 1988-03-08
AU1277688A (en) 1988-09-08
IL85476A0 (en) 1988-07-31
ZA881657B (en) 1988-09-06
EP0281809A3 (en) 1990-06-06
GR3009565T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-02-28
FI881061A0 (fi) 1988-03-08
CA1318249C (en) 1993-05-25

Similar Documents

Publication Publication Date Title
HU201681B (en) Process for producing retarde parenteral pharmaceutical composition containing growth hormone
US5456922A (en) Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
DE69734607T2 (de) Langwirkende arzneistoffe und diese enthaltende arzneimittel
DE69420632T2 (de) Verfahren zur Herstellung von Arzneizubereitungen mit verzögerter Wirkstoffabgabe
DE3520228C2 (de) Wasserlösliche bioaktive Trockenfeststoffzusammensetzung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
KR890004687B1 (ko) 생물학적 활성 서방출성 조성물
DE69312947T2 (de) Proteinhaftige arzneimittel mit verzögerter wirkstoffabgabe
DD273004A5 (de) Verfahren zur herstellung von humanprotein praeparaten
DE2423831A1 (de) Verfahren zur aktivierung von kohlehydraten fuer die umsetzung mit proteinen
DE3207480A1 (de) Praeparat mit ausgezeichneten absorptionseigenschaften
KR20030023878A (ko) 소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들
DD235827A5 (de) Verfahren zur herstellung eines resorbierbaren antibiotika-depots
EP0291863B1 (de) Mischkristalle aus Insulin und Insulinderivaten, Verfahren zur Herstellung dieser Mischkristalle und diese Mischkristalle enthaltende pharmazeutische Mittel
DE69321215T2 (de) Ester aus pektin und pektinische saure
DE2603122C3 (de) Verfahren zum Herstellen von Glykoproteinen sowie deren Verwendung
EP0116358B1 (de) Komplexe von Prostaglandinen
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
DE69231263T2 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
KR100890679B1 (ko) 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
NZ226723A (en) Injectable sustained release formulation comprising polypeptide dispersed in an absorbable biocompatible base
DD258992A1 (de) Verfahren zum gleichzeitigen trocknen und granulieren von extaktstoffen aus enteiweissten kaelberblut
DE69828503T2 (de) Neue kohlenhydrate und ihre verwendung
CA1063514A (en) Water-soluble composition comprising sulfadimidine and pyrimethamine
DE3417022C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP3990767B2 (ja) 果実増糖減酸用合成組成物

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee